openPR Logo
Press release

Healthcare Regulatory Affairs Outsourcing Market | Parexel International Corporation, Pharmaceutical Product Development, Medelis, Inc., Quintiles Transnational Holdings, Inc., Charles River Laboratories International, Inc., KAI Research, Inc., Medpace, I

03-29-2019 06:57 AM CET | Health & Medicine

Press release from: TMR Research

Healthcare Regulatory Affairs Outsourcing Market | Parexel International Corporation, Pharmaceutical Product Development, Medelis, Inc., Quintiles Transnational Holdings, Inc., Charles River Laboratories International, Inc., KAI Research, Inc., Medpace, I

The healthcare regulatory affairs outsourcing market is experiencing significant growth owing to services to Clinical Research Organizations. The rising number of patent expirations along with growing costs of research and development activities are the primary factors influencing the growth of the global healthcare regulatory affairs outsourcing market. Healthcare and biopharmaceutical organizations are likely to team up with numerous outsourcing companies for getting their drugs and devices approved in the global market. The approval time of a drug or device is a time taking process, is expensive, and is also a documentation centric procedure.

As a result of the above, the service providers have been shifting their focus to outsource healthcare regulatory activities for reducing costs and focusing on core competencies. These type of regulatory service providers provide several other services as well such as pharmacovigilance, medical writing, and clinical trials to biotech and many different countries. However, the market is expected to be inhibited by the high fluctuations in price along with hidden expenses in the regulatory services delivered by diverse Clinical Research Organizations. Furthermore, high risks pertaining to organizational information security is likely to challenge the productivity of the healthcare regulatory affairs outsourcing market.

Get Brochure of the Report @ www.tmrresearch.com/sample/sample?flag=B&rep_id=77

The service providers of healthcare regulatory affairs outsourcing can gain lucrative growth opportunities from emerging economies in Latin America and Asia Pacific owing to the developing infrastructure of these regions and investments in developing healthcare technologies.

Global Healthcare Regulatory Affairs Outsourcing Market: Overview

Regulatory policies are implemented to ensure that companies comply with certain standards of functioning in relation to their businesses. These policies or regulatory affairs in the healthcare industry are aimed at safeguarding the public health and welfare by ensuring the safety of pharmaceutical and healthcare products. An increasing number of healthcare companies lately are outsourcing their regulatory functions to focus on their core competencies instead. Furthermore, due to the advent of an increasing number of drugs in the clinical development process, regulatory affair outsourcing is gaining more importance in the healthcare sector.

TMR Research, in its new report studies the prevalent prospects for the market. Based on in-depth analysis and exhaustive information obtained through proven research methodologies it also presents refined outlook for the market between 2017 and 2025.

Global Healthcare Regulatory Affairs Outsourcing Market: Trends and Opportunities

An increasing number of healthcare institutes and pharmaceutical companies are outsourcing regulatory affairs to save cost and capitalize on expertise available with the contract research organizations (CROs). Outsourcing healthcare regulatory affairs provides these organizations with the time and resource to focus on their core competencies, which is the chief driver of the global healthcare regulatory affairs outsourcing market.

Currently, regulatory support is available for almost every process across clinical trials such as medical report writing, manufacturing and controls (CMC), data management, regulatory chemistry, country regulatory affairs, labeling and liaison, and regulatory strategy. One of the primary benefits of outsourcing regulatory affairs is cost effectiveness. Outsourcing non-core activities to experts can help companies focus more on their marketing and research and development activities. Hence in the long run companies can benefit from optimized reimbursements, product approval, and increased market share and productivity. Spurred by these factors, the global healthcare regulatory outsourcing market is poised to exhibit strong growth over the forecast period.

Global Healthcare Regulatory Affairs Outsourcing Market: Regional Outlook

Regionally, Asia Pacific, North America, Europe, and Rest of the World constitute the key market segments. Among these, North America emerged dominant as the U.S. held lead in the global healthcare regulatory affairs outsourcing market. Europe trailed North America as leading healthcare institutes therein increased their focus on reducing investment cost and capitalize on the availability of cheap labor. Besides this, the rising concentration on the optimum utilization of resources and gain from accelerated focus on faster product approval.

Owing to the high costs involved in clinical development procedures in developed nations, the emerging countries are more preferred for regulatory affairs outsourcing in the healthcare sector. Asia Pacific for instance is exhibiting impressive CAGR and is fast emerging as a lucrative market for regulatory affairs outsourcing. The growth of Asia Pacific market is spurred due to the availability of a large pool of skilled labor at an affordable price and the increasing number of pharmaceutical companies intending to focus on their core competencies.

Global Healthcare Regulatory Affairs Outsourcing Market: Vendor Landscape

Various companies around the world offer comprehensive knowledge in managing healthcare regulatory affairs. These companies mainly intend to help firms overcome challenges and accelerate clinical processes. Some of the leading players in the market identified by the report are Covance Group Ltd., Parexel International Corporation, Pharmaceutical Product Development, Medelis, Inc., Quintiles Transnational Holdings, Inc., Charles River Laboratories International, Inc., KAI Research, Inc., Medpace, Inc., and ICON Plc.

Get TOC for Detailed Facts and Numbers @ www.tmrresearch.com/sample/sample?flag=T&rep_id=77

The report conducts SWOT analysis on several of these market players to gauge determine their strengths and weaknesses. This analysis also provides insights into the opportunities and threats that potentially lay ahead for these companies over the course of the forecast period.

Highlights of the report:

A detailed analysis of key segments of the market
Recent developments in the market’s competitive landscape
Detailed analysis of market segments up to second or third level of segmentation
Historical, current, and projected future valuation of the market in terms of revenue and/or volume
Key business strategies adopted by influential market vendors
Outline of the regulatory framework surrounding and governing numerous aspects of the market
Growth opportunities in emerging and established markets
Recommendations to market players to stay ahead of the competition

About Us:
TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Contact Us:
Rohit Bhisey
Head Internet Marketing
Tel: +1-415-520-1050

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Healthcare Regulatory Affairs Outsourcing Market | Parexel International Corporation, Pharmaceutical Product Development, Medelis, Inc., Quintiles Transnational Holdings, Inc., Charles River Laboratories International, Inc., KAI Research, Inc., Medpace, I here

News-ID: 1678138 • Views: 1392

More Releases from TMR Research

Farm Animal Drug Market 2025 | Zydus Animal Health Ltd., Zoetis, Inc.
Global Farm Animal Drug Market: Snapshot Farm animal drugs are medicines mainly used for healthcare-based practices for diagnosis, cure, mitigation, treatment, or prevention of diseases that could affect livestock. These medicines need to be used as per strict requirement based on their essentiality to maintain well-being of farm animals. Simply said, farm animal drugs are a key factor supporting the growth of livestock industry all over the globe. Get Sample Copy of
Survey On Innovation: Immune Thrombocytopenia Drugs Market 2028 | Rigel Pharmace …
Immune Thrombocytopenia Drugs Market: Overview The autoimmune disorder of immune thrombocytopenia outcomes in an unusually low level of platelets. Asymptomatic bleeding disorders are immune thrombocytopenia. Only after platelet counts are exceptionally low appear symptoms. These are petechias, skin contusions, bleeding from the rubber gum, among others. While most of the ITP aren’t fatal cases, roughly 3 per cent die from complication like intracranial hemorrhages and infection in chronic refractory ITP patients.
Neglected Tropical Disease Treatment Market Landscape Assessment By Type, Opport …
Global Neglected Tropical Disease Treatment Market: Introduction Relevant issues like sanitation, neatness, and cleanliness still stress a few pieces of the world even today. This outcomes in spike of contaminations and diseases that usually get neglected. They are named as neglected tropical diseases. World Health Organization states that these malady influence almost 1 billion individuals over the globe. This clarifies the upcoming potential for organizations in the global neglected tropical
Business Overview: Uveitis Drugs Market 2028 | Allergan India Private Limited, T …
Global Uveitis Drugs Market: Overview A limited choice of commercial drugs composed of corticosteroid treatments, immunosuppresives and biologics is characteristic of the global uveitis drugs market. Uveitis (Uveitis) is a median eye inflammation (Uvea) known as the uvea tract. The uvea is made up of iris, ciliary and choroids. Certain prevalent causes of uveitis are autoimmune diseases, infection, injury, inflammatory diseases and surgeries. Uveitis-related common symptoms include eye pain, floating

All 26115 Releases


More Releases for Outsourcing

Mortgage Underwriting Services Outsourcing
Mortgage Underwriting Services Outsourcing Category :- News/ Business/Finance/ Mortgage Texas (USA), Canada (Toronto) & India (Business Network)— Suma Soft’s Outsourcing Mortgage Underwriting Services assist mortgage lenders to efficiently streamline business processes involved in mortgage underwriting. Suma Soft has developed an integrated mortgage loan origination process that ensures collection, organization and evaluation of required documents are done before the loan is submitted for underwriting. Maintaining Secrecy & provides round the clock support Suma
Outsourcing Services | Outsourcing Services
Intelgain Technologies, (previously known as Dynamic Web Technologies) is a certified Software solutions provider that delivers unique enterprise IT solutions, making your most complex, mission-critical projects simple and easy to handle. We partner you through strategic implementation of technology, backed by solid domain and industry expertise. Besides Custom Web, Bespoke Software Application development, we offer software consultancy, design, maintenance and support. We integrate, automate optimize Global business, using best-of-breed practices,
Outsourcing Companies in India
India continues to be a preferred venue for those companies simply believing in hiring reasonable services that fall within budget and are affable as well. The outsourcing companies in India make it a point to keep their service affordable. They cater to a diverse client group, each approaching them with different projects. The size of these projects varies and each has its own set of requirements. So the pricing is
Lviv Outsourcing Forum 2010
LVIV, Ukraine – March 29, 2010 – N-iX, Ukrainian IT outsourcing provider of software solutions and engineering services, has taken part in Lviv Outsourcing Forum 2010 on March 27. First Outsourcing Forum took place in Lviv, on March 27. This conference was dedicated to mechanisms of customers’ stream generation. The point was to examine issues of attracting customers to outsourcing projects, problems of projects’ specialization and general Lviv attractiveness for IT-BPO
Procurement Outsourcing
Outsourcing industry is growing rapidly as more and more companies are realizing the benefits of outsourcing. Initially it was limited to non-core business areas like data management, surveys, administration, and customer service and so on. Now many companies have started outsourcing their procurement jobs, primarily in the non-core items like common raw materials for production, office stationary etc. Recent survey report on 150 outsourcing companies in US shows that nearly half
Offshore Outsourcing
Top 10 Reasons to Outsource FX: Increase revenues and profits derived from fee-based services Improve operational efficiencies and productivity level by automating administrative tasks. Deliver values to customers to enhance business relationships Expand services line to capture more business from existing customers achieve more competitive exchange rate through wholesale purchasing Control cost. If cash is not tied up in capital expenses, it can be reinvested in areas offering the greatest return